Mawadda Chukr: What 10 Randomized Trials Reveal About Novel ITP Therapies
Mawadda Chukr, Student at Aleppo University, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Cytokine, adding:
“My first publication is officially out in Q1
We looked at novel therapies (SYK, FcRn, and BTK inhibitors) for adult Immune Thrombocytopenia (ITP) through a systematic review and meta-analysis of 10 RCTs.
I am so grateful to my co-authors for this amazing collaboration.
Check out the graphic below for our key highlights, or read the full paper via the link!”
Title: Efficacy and safety of IgG-pathway inhibitors in adult immune thrombocytopenia: A systematic review and meta-analysis with subgroup analyses of FcRn and SYK inhibitors
Authors: Mousa Almasalma, Ahmed Hamdy Kandil, Mahmoud Hashem Al-Qadi, Mohamed Lotfy Maarouf, Sara Mohammad Altaamreh, Weaam A. Soliman, Ahmed S. Mohamed, Ahmed Boshta, Nereen A. Almosilhy, Bashar Zahir Alsalhen, Mawadda Chukr
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering